Lacosamide Partial Onset Seizures

Links shared publicly online about this topic

Lacosamide Validated As Promising Therapy For Uncontrolled Partial-Onset Seizures

medicalnewstoday.com — “A recent multi-center study has confirmed earlier study results that 400 mg/day of lacosamide provides a good balance of efficacy and tolerability for patients with uncontrolled partial-onset seizView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on February 26, 2010 at 4:07 pm By:

mnt_epilepsy MNT Epilepsy News Health News

Lacosamide Validated As Promising Therapy For Uncontrolled Partial-Onset Seizures http://mnt.to/3ybp #epilepsy

2 years ago...

Lacosamide validated as promising therapy for uncontrolled partial-onset seizures

physorg.com — “A recent multi-center study has confirmed earlier study results that 400 mg/day of lacosamide provides a good balance of efficacy and tolerability for patients with uncontrolled partial-onset seizures (POS), and doses of 600mg/day may provide additional benefit for some patients. Researchers from the ...View full resource at physorg.com

  • View Related
  • Share

Most Recently Shared on February 25, 2010 at 7:11 pm By:

physorg_health PhysOrg Health News Health News

Lacosamide validated as promising therapy for uncontrolled partial-onset seizures http://tw.physorg.com/186329360

2 years ago...

Lacosamide validated as promising therapy for uncontrolled partial-onset seizures

sciencedaily.com — “A recent multi-center study has confirmed earlier study results that 400 mg/day of lacosamide provides a good balance of efficacy and tolerability for patients with uncontrolled partial-onset seizures, and doses of 600mg/day may provide additional benefit for some patients.View full resource at sciencedaily.com

  • View Related
  • Share

Most Recently Shared on March 9, 2010 at 9:07 pm By:

medical_tweets medical_tweets Health News

Lacosamide validated as promising therapy for uncontrolled partial-onset seizures A recent multi-center study has con.. http://bit.ly/8X1cZx

2 years ago...

Sustained Efficacy Of Vimpat (Lacosamide) In Reducing Partial Onset Of Seizures For Up To Eight Years

medicalnewstoday.com — “The 29th International Epilepsy Congress in Rome, Italy (28th August-1st September) 1-4 presented consistent evidence this week, that a combined treatment with Vimpat® (lacosamide) has generalView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on September 2, 2011 at 7:04 am By:

Epilepsy_Wisdom Epilepsy OW OW Health

Sustained Efficacy Of Vimpat (Lacosamide) In Reducing Partial Onset Of Seizures For Up To Eight Years: The 29th ... http://t.co/Mec2KWC

9 months ago...

Vimpat (lacosamide) provided sustained efficacy and good tolerability for up to 8 years in patients with partial onset seizures - Drugs.com MedNews

drugs.com — “Long term data from four open label lacosamide extension trials reported at the 29th International Epilepsy Congress New non-interventional study (VITOBA ) aimsView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on September 1, 2011 at 10:01 pm By:

Drugs_Devices Drugs and Devices OW OW Health

Vimpat (lacosamide) provided sustained efficacy and good tolerability for up to 8 years in patients with p... http://t.co/oazh0jZ #drug

9 months ago...

UCB Media Centre - Vimpat® (lacosamide) provided sustained efficacy and good tolerability for up to 8 years in patients with partial onset seizures

ucb.presscentre.com — “For the attention of accredited medical writers only• Long term data from four open label lacosamide extension trials reported at the 29th International Epilepsy Congress • New non-interventional study (VITOBA™) aims to investigate additive or synergistic effects of lacosamide with single antiepileptic drug (AED) treatmentView full resource at ucb.presscentre.com

  • View Related
  • Share

Most Recently Shared on August 31, 2011 at 12:24 pm By:

Vimpat® (lacosamide) Significantly Reduced Partial-Onset Seizures Regardless Of The Mechanism Of Action Of Concomitant Antiepileptic Drugs

medicalnewstoday.com — “Comprehensive analyses of pooled data from three randomized, double-blind, placebo-controlled Phase II/III trials showing the efficacy and tolerability of Vimpat® (lacosamide) C-V for patientsView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on January 13, 2011 at 3:05 pm By:

mnt_pharma MNT Pharma News Health News and Pharma

Vimpat® (lacosamide) Significantly Reduced Partial-Onset Seizures Regardless Of The Mechanism Of Action Of Concomi... http://mnt.to/3PXs

1 year ago...

AED Vimpat demonstrates fewer partial-onset seizures in adults with epilepsy

news-medical.net — “UCB today announced that the antiepileptic drug (AED) Vimpat- (lacosamide) (C-V) demonstrated significantly fewer partial-onset seizures versus placebo in adults living with epilepsy, according to a Phase III clinical study published online in Epilepsia.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on March 12, 2010 at 1:41 pm By:

Parkinsons_News News-Medical.Net Health News

Parkinson's Disease: AED Vimpat demonstrates fewer partial-onset seizures in adults with epilepsy: UCB today anno... http://bit.ly/cjmdNU

2 years ago...

Vimpat (lacosamide) Significantly Reduced Partial-Onset Seizures Regardless of the Mechanism of Action of Concomitant Antiepileptic Drugs - Drugs.com MedNews

drugs.com — “Comprehensive lacosamide analyses published in CNS Drugs - Pooled phase II III clinical trial data demonstrated efficacy and tolerability of lacosamide as adjunView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on January 12, 2011 at 7:18 pm By:

Drugs_Devices Drugs and Devices OW OW Health

Vimpat (lacosamide) Significantly Reduced Partial-Onset Seizures Regardless of the Mechanism of Action of ... http://bit.ly/dQh82u #drug

1 year ago...

Long-term Use of Antiepileptic Drug Vimpat (Lacosamide) C-V Effectively Reduced Partial-Onset Seizure Frequency and Improved Health-related Quality of Life - Drugs.com MedNews

drugs.com — “Data presented at the 64th Annual Meeting of the American Epilepsy Society - First presentation of the effects of long-term Vimpat treatment on patients self-reView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on December 7, 2010 at 9:07 pm By:

Drugs_Devices Drugs and Devices OW OW Health

Long-term Use of Antiepileptic Drug Vimpat (Lacosamide) C-V Effectively Reduced Partial-Onset Seizure Freq... http://bit.ly/gFrSKZ #drug

1 year ago...

Vimpat provides long-term additional partial-onset seizure control when added to broad range of AEDs

news-medical.net — “New long term data showed that Vimpat- (lacosamide) C-V provided sustained reduction in seizure frequency for up to five years when used as an add-on treatment for uncontrolled partial onset seizures in adults with epilepsy. In addition post-hoc exploratory analyses showed that adjunctive lacosamide treatment reduced partial-onset seizure frequency and improved responder rates when added to a broad range of antiepileptic drugs (AEDs) including both traditional sodium channel-blocking agents and View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on June 30, 2010 at 12:59 pm By:

Epilepsy_News News-Medical.Net Health News

Epilepsy News: Vimpat provides long-term additional partial-onset seizure control when added to broad range of AED... http://bit.ly/bDYwk4

2 years ago...

Epilepsy: Adjunctive Rufinamide Reduces Refractory Partial-Onset Seizures

medicalnewstoday.com — “Researchers from the Arkansas Epilepsy Program found treatment with rufinamide results in a significant reduction in seizure frequency compared with placebo, for patients with uncontrolled partialView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on October 4, 2010 at 3:05 pm By:

mnt_epilepsy MNT Epilepsy News Health News

Epilepsy: Adjunctive Rufinamide Reduces Refractory Partial-Onset Seizures http://mnt.to/3KJ7 #epilepsy

2 years ago...

ingentaconnect Retigabine (Ezogabine): In Partial-Onset Seizures in Adults with ...

ingentaconnect.com — “ingentaconnect Retigabine (Ezogabine): In Partial-Onset Seizures in Adults with ...View full resource at ingentaconnect.com

  • View Related
  • Share

Most Recently Shared on September 26, 2011 at 5:06 am By:

Neurology_OW Neurology OW OW Health

Retigabine (Ezogabine): In Partial-Onset Seizures in Adults with Epilepsy: (Source: CNS Drugs) http://t.co/PB9Wp1QV

8 months ago...

Adjunctive rufinamide reduces refractory partial-onset seizures

physorg.com — “Researchers from the Arkansas Epilepsy Program found treatment with rufinamide results in a significant reduction in seizure frequency compared with placebo, for patients with uncontrolled partial-onset seizures (POS). Details of this study are now available online in Epilepsia, a journal published ...View full resource at physorg.com

  • View Related
  • Share

Most Recently Shared on October 1, 2010 at 9:51 am By:

physorg_health PhysOrg Health News Health News

Adjunctive rufinamide reduces refractory partial-onset seizures http://tw.physorg.com/205131053

2 years ago...

Trobalt / Potiga – Treatment for Partial-Onset Seizure - Drug Development Technology

drugdevelopment-technology.com — “Trobalt (Ezogabine / Retigabine) is indicated for the treatment of partial-onset epileptic seizures in patients aged more than 18 years old. It is being developed and manufactured jointly by Canada-based Valeant Pharmaceuticals and...View full resource at drugdevelopment-technology.com

  • View Related
  • Share

Most Recently Shared on September 28, 2011 at 5:26 pm By:

Epilepsy_Wisdom Epilepsy OW OW Health

Trobalt / Potiga – Treatment for Partial-Onset Seizure: Trobalt (Ezogabine / Retigabine) is indicated for the ... http://t.co/9rqjiggX

8 months ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Related Health Centers

Featuring the top 3 experts for this topic

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390